Jean-Yves Nothias
Oprichter bij Vesale Partners SAS
Oorsprong van het eerstegraads netwerk van Jean-Yves Nothias
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities.
15
| Subsidiary | Investment Managers | 15 |
| Public Company | Medical Specialties | 14 | |
Université Pierre et Marie Curie
14
| Extinct | Other Consumer Services | 14 |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.
10
| Private Company | Investment Managers | 10 |
Université de Paris IV Paris-Sorbonne
6
| Extinct | Other Consumer Services | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Yves Nothias via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| DASSAULT SYSTÈMES SE | Packaged Software | Director/Board Member Director of Finance/CFO | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director/Board Member | |
| MDXHEALTH SA | Medical Specialties | Director/Board Member Director/Board Member | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| University of British Columbia | College/University | Doctorate Degree Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Doctorate Degree Masters Business Admin | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Corporate Officer/Principal Graduate Degree | |
| Université Libre de Bruxelles | College/University | Corporate Officer/Principal Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Trod Medical NV
 Trod Medical NV Medical SpecialtiesHealth Technology Trod Medical NV develops and commercializes tools for use in the focal ablation of soft tissues. The company was founded by Andre Scattolin Faure on June 29, 2006 and is headquartered in Leuven, Belgium. | Medical Specialties | Director/Board Member Director/Board Member | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree | |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member Director/Board Member | |
Creadev SASU
 Creadev SASU Investment ManagersFinance CREADEV SAS (CREADEV) is an independent French capital investment firm which was founded in 2002. Headquartered in Paris, CREADEV is the investment holding of the Mulliez Family. The firm works autonomously, investing in innovative French companies across business sectors which harness emerging megatrends in today's society. CREADEV donates their business management expertise to the 'A chacun son Everest' Association, which helps children in remission from cancer. | Investment Managers | Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Voltalis SA
 Voltalis SA Electronic Equipment/InstrumentsElectronic Technology Voltalis SA engages in the design, production and installation of electricity consumption regulation tools for grid operator. Its solutions include PV self-consumption, Subsitute to thermal plant, Ancillary services, Renewable firming, Dynamic pricing, Peak demand management, Congestion management, Home Energy Management & Apps, Alert, Remote control, Virtual thermostat and, Comparison / advice. The company was founded by Pierre Bivas in 2006 and is headquartered in Paris, France. | Electronic Equipment/Instruments | Director/Board Member | |
Worldwide Clinical Research, Inc.
 Worldwide Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., Worldwide Clinical Research, Inc. provides management consulting services to the clinical research industry. The company is based in Overland Park, KS. The company was founded by Barbara J. Geiger. Worldwide Clinical Research was acquired by Clinipace, Inc., part of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. from April 28, 2021 on November 09, 2009. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Force-A SAS
 Force-A SAS Electronic Equipment/InstrumentsElectronic Technology Force-A SAS manufactures telemetry systems for agricultural purposes. It offers optical sensors and data processing modules for monitoring diagnostic factors, such as chlorophyll levels and nitrogen balance, in real time. The company was founded by Jean-Luc Ayral and Zoran Cerovic in 2004, and is headquartered in Orsay, France. | Electronic Equipment/Instruments | Director/Board Member | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Chief Executive Officer Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Chairman Chairman | |
| Vesalius Biocapital II Partners SARL | Corporate Officer/Principal Founder | ||
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member | |
Essling Capital SAS
 Essling Capital SAS Investment ManagersFinance Essling Capital SAS (Essling Capital) is an independent private equity firm founded in 2016 by Frank-Noël Vandenberghe. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Undergraduate Degree | |
Vantage Infrastructure (UK) Ltd.
 Vantage Infrastructure (UK) Ltd. Investment ManagersFinance Vantage Infrastructure Ltd (Vantage Infrastructure) is an independent private equity firm founded in 1994. The firm is headquartered in London. | Investment Managers | Investment Committee Member | |
Actility SA
 Actility SA Information Technology ServicesTechnology Services Actility SA engages in the provision of low power wide area network solutions. It enables and supports communication service providers, device manufacturers, and application suppliers. Its products includes ThingPark Wireless, OS, X, Energy, and Market. The company was founded by Olivier Hersent, Boris Dezier, Nicolas Jordan, and Bernard Jannes on May 12, 2010 and is headquartered in Paris, France. | Information Technology Services | Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 20 |
| Verenigde Staten | 15 |
| België | 7 |
| Verenigd Koninkrijk | 5 |
| Canada | 3 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 287 |
| Corporate Officer/Principal | 155 |
| Independent Dir/Board Member | 63 |
| Chief Tech/Sci/R&D Officer | 48 |
| Private Equity Investor | 45 |
Sterkste connecties
| Insiders | |
|---|---|
| Stéphane Verdood | 32 |
| Alain Parthoens | 29 |
| Edward Penhoet | 29 |
| Mounia Chaoui-Roulleau | 27 |
| Ann Hanham | 26 |
| Steven Gilman | 25 |
| Geneviéve B. Berger | 23 |
| Dina Chaya | 23 |
| Patrick J. Langlois | 23 |
| Eliseo Salinas | 22 |
| Pamela Kirby | 22 |
| Laurent Arthaud | 21 |
| Bernard Malfroy-Camine | 17 |
| Christian Schneider | 17 |
| Gilles Schang | 17 |
- Beurs
- Insiders
- Jean-Yves Nothias
- Bedrijfsconnecties
